Autolus For Profit
Autolus is in T-cell programming and manufacturing technology.
Investors
Industry:
Regenerative medicine
Technology:
Other
Estimated Revenue:
$50M to $100M
Investors Number:
4
Headquarters:
London, England, United Kingdom
Total Funding:
â¬25M
Last Funding Type:
Series A